Stereoselectivity of Limonene Epoxide Hydrolase
A R T I C L E S
throughput ee assays based on standard automated GC or HPLC,
but such libraries need to be characterized by superior quality,
meaning a high frequency of hits showing pronounced catalyst
improvement.10
Our contribution to achieving expediency in this endeavor is
iterative saturation mutagenesis (ISM), which can be applied to
the control of stereoselectivity7,10 and to the enhancement of
thermostability and robustness in hostile organic solvents.10b
Appropriate sites in an enzyme, labeled A, B, C, D, etc., each
comprising one or more amino acid positions, are subjected to
saturation mutagenesis with formation of focused libraries. Sub-
sequently, the hits in the libraries are used as templates to perform
saturation mutagenesis at the respective other sites, and the process
is continued iteratively until the desired degree of catalyst improve-
ment has been achieved (for a 4-site ISM scheme, see Scheme S4
in the Supporting Information). When evolving stereoselectivity
and/or substrate scope (rate), the criterion for choosing appropriate
sites is based on the Combinatorial Active Site-Saturation Test
(CAST),7,10a,c,d according to which residues aligning the binding
pocket are considered. A further tool in “smart” library creation is
the use of reduced amino acid alphabets employing the appropriate
codon degeneracy, because this decimates the degree of oversam-
pling .7,10 In the present study we wanted to test the utility of ISM
in the evolution of stereoselective LEH mutants. At the outset of
the project, stringent requirements were defined by restricting the
size of the mutant libraries to a few thousand transformants, i.e.,
we wanted to know how far one can get by investing a minimum
amount of laboratory work. In contrast to several other EHs,12 LEH
has not been subjected to directed evolution previously.
which means that wild-type (WT) LEH can hardly be exploited
in synthetic organic chemistry. As an example, it catalyzes the
hydrolytic desymmetrization of cyclopentene-oxide (3) with
poor enantioselectivity (ee ) 14% in meager favor of (R,R)-4).
Hoping to obtain LEH mutants which catalyze the formation
of (R,R)-4 and (S,S)-4 on an optional basis with high enanti-
oselectivity, we decided to apply directed evolution.6,7 Since
industrial organic chemists need stereoselective catalysts with
a reasonable substrate scope,8 not just one for the reaction of a
single compound, we also planned to test the evolved mutants
in the reaction of other substrates without performing additional
mutagenesis experiments.
Directed evolution of stereoselective enzymes has emerged
as a prolific source of catalysts for asymmetric transformations
in synthetic organic chemistry.6,7 The bottleneck of laboratory
evolution is the screening step which is particularly challenging
when assaying stereoselectivity.9 Therefore, we and others have
recently stressed “quality, not quantity”.7,10,11 Small mutant
libraries of the order of 100-800 members (transformants) can
be screened for enantioselectivity within 1 day using medium-
Results and Discussion
Initial Saturation Mutagenesis Experiments. LEH is a 149
amino acid (16.5 kDa) enzyme which has been characterized
by X-ray crystallography of a sample containing the inhibitor
valpromide (2-n-propylpentanoic acid amide).3b In order to make
a sound decision regarding proper CAST sites for saturation
mutagenesis, we first performed induced fit docking of the model
substrate 3 using the published crystal structure. This procedure
led to the identification of eight residues for potential random-
ization, namely, Met32, Leu35, Leu74, Met78, Ile80, Val83,
Leu114, and Ile116 (Figure 1a). The next step required a
decision concerning the question of how to group these amino
acid positions into appropriate sites. In principle, one could opt
for eight single residue sites, a strategy that we successfully
applied in the directed evolution of the enoate-reductase
YqjM.10c Using NNK codon degeneracy (N, adenine/cytosine/
guanine/thymine; K, guanine/thymine) encoding all 20 canonical
amino acids, this would entail eight randomization libraries, each
requiring about 100 transformants to be screened for 95% library
coverage assuming the absence of amino acid bias.10
(6) Recent reviews of directed evolution:7(a) Johannes, T. W.; Zhao, H.
Curr. Opin. Microbiol. 2006, 9, 261–267. (b) Lutz, S.; Bornscheuer,
U. T. Protein Engineering Handbook; Wiley-VCH: Weinheim, 2009;
Vols. 1-2. (c) Turner, N. J. Nat. Chem. Biol. 2009, 5, 567–573. (d)
Ja¨ckel, C.; Kast, P.; Hilvert, D. Annu. ReV. Biophys. Biomol. Struct.
2008, 37, 153–173. (e) Bershtein, S.; Tawfik, D. S. Curr. Opin. Chem.
Biol. 2008, 12, 151–158. (f) Romero, P. A.; Arnold, F. H. Nat. ReV.
Mol. Cell Biol. 2009, 10, 866–876. (g) Reetz, M. T. In Asymmetric
Organic Synthesis with Enzymes; Gotor, V., Alfonso, I., Garc´ıa-
Urdiales, E., Eds.; Wiley-VCH: Weinheim, 2008; pp 21-63. (h) Otten,
L. G.; Hollmann, F.; Arends, I. W. C. E. Trends Biotechnol. 2010,
28, 46–54. (i) Shivange, A. V.; Marienhagen, J.; Mundhada, H.;
Schenk, A.; Schwaneberg, U. Curr. Opin. Chem. Biol. 2009, 13, 19–
25.
(7) Review of directed evolution of stereoselective enzymes:6g Reetz, M. T.
Angew. Chem. 2010, 122, DOI: 10.1002/ange.201000826. Angew.
Chem., Int. Ed. 2010, 49, DOI: 10.1002/anie.201000826.
(8) (a) Breuer, M.; Ditrich, K.; Habicher, T.; Hauer, B.; Keꢀeler, M.;
Stu¨rmer, R.; Zelinski, T. Angew. Chem. 2004, 116, 806–843. Angew.
Chem., Int. Ed. 2004, 43, 788-824. (b) Blaser, H.-U.; Schmidt, E.
Asymmetric Catalysis on Industrial Scales; Wiley-VCH: Weinheim,
2004. (c) Berkessel, A.; Gro¨ger, H. Asymmetric Organocatalysis;
Wiley-VCH: Weinheim, 2004. (d) Tao, J.; Lin, G.-Q.; Liese, A.
Biocatalysis for the Pharmaceutical Industry; Wiley-VCH: Weinheim,
2009.
In other studies, however, we discovered that randomization
at sites composed of more than one amino acid position lead to
(9) (a) Reymond, J.-L.; Fluxa`, V. S.; Maillard, N. Chem. Commun.
(Cambridge, U. K.) 2009, 34–46. (b) Reymond, J.-L. Enzyme Assays
- High-throughput Screening, Genetic Selection and Fingerprinting;
Wiley-VCH: Weinheim, 2006. (c) Reetz, M. T. In Enzyme Assays -
High-throughput Screening, Genetic Selection and Fingerprinting;
Reymond, J.-L., Ed.; Wiley-VCH: Weinheim, 2006; pp 41-76.
(10) (a) Reetz, M. T.; Kahakeaw, D.; Lohmer, R. ChemBioChem 2008, 9,
1797–1804. (b) Reetz, M. T.; Carballeira, J. D. Nat. Protoc. 2007, 2,
891–903. (c) Bougioukou, D. J.; Kille, S.; Taglieber, A.; Reetz, M. T.
AdV. Synth. Catal. 2009, 351, 3287–3305. (d) Reetz, M. T.; Prasad,
S.; Carballeira, J. D.; Gumulya, Y.; Bocola, M. J. Am. Chem. Soc.
2010, 132, 9144–9152.
(12) Directed evolution of other EHs:10a(a) Reetz, M. T.; Torre, C.; Eipper,
A.; Lohmer, R.; Hermes, M.; Brunner, B.; Maichele, A.; Bocola, M.;
Arand, M.; Cronin, A.; Genzel, Y.; Archelas, A.; Furstoss, R. Org.
Lett. 2004, 6, 177–180. (b) Reetz, M. T.; Wang, L.-W. Angew. Chem.
2006, 118, 1258–1263, in part M. Bocola. Angew. Chem. Int. Ed. 2006,
45, 1236-1241. Erratum. Angew. Chem. Int. Ed. 2006, 45, 2556.
Erratum. Angew. Chem. Int. Ed. 2006, 45, 2494. (c) van Loo, B.; Lutje
Spelberg, J. H.; Kingma, J.; Sonke, T.; Wubbolts, M. G.; Janssen,
D. B. Chem. Biol. 2004, 11, 981–990. (d) Lee, E. Y.; Shuler, M. L.
Biotechnol. Bioeng. 2007, 98, 318–327. (e) Rui, L.; Cao, L.; Chen,
W.; Reardon, K. F.; Wood, T. K. Appl. EnViron. Microbiol. 2005,
ˇ
71, 3995–4003. (f) Kotik, M.; Steˇpa´nek, V.; Kysl´ık, P.; Maresˇova´, H.
(11) Lutz, S.; Patrick, W. M. Curr. Opin. Biotechnol. 2004, 15, 291–297.
J. Biotechnol. 2007, 132, 8–15.
9
J. AM. CHEM. SOC. VOL. 132, NO. 44, 2010 15745